We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.32B
AUM Growth
+$155M
Cap. Flow
-$100M
Cap. Flow %
-1.89%
Top 10 Hldgs %
16.3%
Holding
739
New
50
Increased
312
Reduced
249
Closed
35

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$31M
2
CL icon
Colgate-Palmolive
CL
+$20M
3
MRK icon
Merck
MRK
+$18.8M
4
GLW icon
Corning
GLW
+$18.5M
5
FFIV icon
F5
FFIV
+$17.2M

Sector Composition

Rank Sector Weight
1 Healthcare 25.58%
2 Technology 13.62%
3 Financials 13.2%
4 Consumer Discretionary 9.51%
5 Industrials 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BEN icon
51
Franklin Resources
BEN
$16.8B
$22.5M 0.42%
501,556
+395,472
+373% +$16.9M
HD icon
52
Home Depot
HD
$324B
$22.1M 0.42%
144,131
+17,605
+14% +$2.7M
GOOG icon
53
Alphabet (Google) Class C
GOOG
$3.88T
$21.8M 0.41%
479,280
+19,740
+4% +$904K
KO icon
54
Coca-Cola
KO
$349B
$21.5M 0.4%
478,549
+99,174
+26% +$4.38M
CBRE icon
55
CBRE Group
CBRE
$39.7B
$21.2M 0.4%
583,681
+145,627
+33% +$5.06M
CMCSA icon
56
Comcast
CMCSA
$78.3B
$21.2M 0.4%
545,453
+47,362
+10% +$1.87M
NBIX icon
57
Neurocrine Biosciences
NBIX
$17.5B
$21.2M 0.4%
461,000
+214,000
+87% +$10.4M
DFS
58
DELISTED
Discover Financial Services
DFS
$21.2M 0.4%
340,796
+29,538
+9% +$1.83M
PG icon
59
Procter & Gamble
PG
$342B
$20.1M 0.38%
230,279
+2,594
+1% +$229K
CRM icon
60
Salesforce
CRM
$129B
$19.7M 0.37%
228,033
-57,949
-20% -$5.05M
ISRG icon
61
Intuitive Surgical
ISRG
$119B
$19.2M 0.36%
184,545
+25,020
+16% +$2.4M
LNC icon
62
Lincoln National
LNC
$7.81B
$19.1M 0.36%
282,468
+15,530
+6% +$1.03M
EL icon
63
Estee Lauder
EL
$28.9B
$19M 0.36%
198,385
-5,231
-3% -$480K
A icon
64
Agilent Technologies
A
$39.5B
$18.9M 0.36%
318,612
+64,213
+25% +$3.66M
PEP icon
65
PepsiCo
PEP
$184B
$18.9M 0.35%
163,483
-351,836
-68% -$40.4M
BMRN icon
66
BioMarin Pharmaceuticals
BMRN
$11.4B
$18.6M 0.35%
205,100
+21,490
+12% +$1.96M
ROK icon
67
Rockwell Automation
ROK
$51.3B
$18.6M 0.35%
114,866
-23,378
-17% -$3.69M
HIG icon
68
Hartford Financial Services
HIG
$39B
$18.4M 0.35%
350,065
-111,802
-24% -$5.54M
DGX icon
69
Quest Diagnostics
DGX
$25.2B
$17.9M 0.34%
161,178
-60,423
-27% -$6.39M
BDX icon
70
Becton Dickinson
BDX
$42.1B
$17.9M 0.34%
93,859
+18,093
+24% +$3.3M
VLO icon
71
Valero Energy
VLO
$90.6B
$17.4M 0.33%
258,454
-1,935
-0.7% -$126K
CMA
72
DELISTED
Comerica
CMA
$17.4M 0.33%
237,233
-28,176
-11% -$1.98M
M icon
73
Macy's
M
$6.14B
$17.2M 0.32%
740,708
+647,156
+692% +$16.6M
MON
74
DELISTED
Monsanto Co
MON
$17.2M 0.32%
145,134
+1,178
+0.8% +$137K
FFIV icon
75
F5
FFIV
$21.9B
$17M 0.32%
134,106
+131,106
+4,370% +$17.2M

Similar funds

Candriam SCA's Q2 2017 Portfolio in Review

As of Q2 2017, Candriam SCA held 739 positions worth $5.32B, up 3% from $5.17B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA's Q2 2017 filing shows 50 new, 312 increased, 249 reduced and 35 closed positions. Its largest new stake was Raymond James Financial: 164,790 shares worth $8.81M. The largest sale was PepsiCo, an estimated $40.4M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q2 2017 buy was Raymond James Financial: 164,790 shares worth $8.81M.
  • Candriam SCA added most to Kellanova in Q2 2017, an estimated $31M increase.
  • Candriam SCA's biggest Q2 2017 reduction was PepsiCo, cutting an estimated $40.4M.
  • Candriam SCA fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $20.4M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.32B portfolio in Q2 2017.
  • Candriam SCA opened 50 new positions and closed 35 in Q2 2017.
  • Candriam SCA's portfolio value rose 3% quarter-over-quarter to $5.32B.

Based on Candriam SCA's 13F filing for Q2 2017, filed 31 Jul 2017.